Replies to post #2639 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

I read that Valeants Marinol gets around 80% of the CINV market in Canada...

And isn't Dronabinol sales in US +50m?

I think your right about the NB1222/NB2222 mixup. Both CBD analogues, but NB2222 is for ocular targets. Someone should e-mail PR

Nemus has completed pre-IND meetings.